Halogen-containing metathesis catalysts and methods thereof

US11020730B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11020730-B2
Application numberUS-201716317452-A
CountryUS
Kind codeB2
Filing dateJul 14, 2017
Priority dateJul 15, 2016
Publication dateJun 1, 2021
Grant dateJun 1, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present disclosure provides compounds, compositions, and methods for preparing alkenyl halides and/or haloalkyl-substituted olefins with Z-selectivity. The methods are particularly useful for preparing alkenyl fluorides such as CF 3 -substituted olefins by means of cross-metathesis reactions using halogen-containing molybdenum and tungsten complexes.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method for performing an alkene metathesis reaction, comprising: reacting a first species comprising a first carbon to carbon double bond with a second species comprising a second carbon to carbon double bond in the presence of a compound of formula I-a, to provide at least one product comprising a third carbon to carbon double bond, wherein: a carbon atom of the first carbon to carbon double bond in the first species is substituted with a first substituent selected from halogen and optionally substituted C 1-6 haloalkyl; and the third carbon to carbon double bond in the at least one product comprises a carbon atom of the first carbon to carbon double bond and a carbon atom of the second carbon to carbon double bond, wherein the carbon atom of the first carbon to carbon double bond is substituted with the first substituent; wherein each carbon atom of the first carbon to carbon double bond in the first species is independently substituted with the first substituent; wherein the first species is wherein each of X and Y is independently halogen or independently optionally substituted C 1-6 haloalkyl; or wherein is cis-1,2-dichloroethene or cis 1,2-dibromoethene or cis-1,1,1,4,4,4-hexafluoro-2-butene; or wherein a carbon atom of the first carbon to carbon double bond in the first species is independently substituted with an optionally substituted C 1-6 haloalkyl group, and the at least one product comprises a third carbon to carbon double bond substituted with the optionally substituted C 1-6 haloalkyl group, and wherein the optionally substituted C 1-6 haloalkyl is methyl substituted with one to three halogens, wherein the optionally substituted C 1-6 haloalkyl comprises one or more —F; or wherein the optionally substituted C 1-6 haloalkyl is methyl substituted with one to three halogens, wherein at least one halogen is —F; or wherein the optionally substituted C 1-6 haloalkyl is —CH 2 F, —CHF 2 , —CClF 2 , —CF 3 , —C 2 F 5 , —C 3 F 7 , —C 4 F 9 , —C 5 F 11 , or —C 6 F 13 ; wherein the alkene metathesis reaction is a Z-selective cross-metathesis reaction or a Z-selective ring-opening cross metathesis reaction; and wherein the compound of formula I-a is: M is molybdenum; wherein: R 1 is adamantyl, tert-butyl, 2,6-dichlorophenyl, 2,6-dibromophenyl, 2,6-dimethylphenyl, 2,6-di-t-butylphenyl, 2,6-diisopropylphenyl, or pentafluorophenyl; one of R 2 and R 3 is hydrogen and the other is —C(Me) 3 or is —C(Me) 2 Ph or is phenyl or 2-methoxyphenyl or 2-isopropoxyphenyl; R 4 is 2,6-(2,6-dimethylphenyl) 2 C 6 H 3 , 2,6-(mesityl) 2 C 6 H 3 , 2,6-(2,6-diethylphenyl) 2 C 6 H 3 , 2,6-(2,4,6-triethylphenyl) 2 C 6 H 3 , 2,6-(2,6-diisopropylphenyl) 2 C 6 H 3 , 2,6-(2,4,6-triisopropylphenyl) 2 C 6 H 3 , 2,6-(2,6-di-t-butylphenyl) 2 C 6 H 3 , 2,6-(2,4,6-tri-t-butylphenyl) 2 C 6 H 3 , 2,6-(2,6-diphenylphenyl) 2 C 6 H 3 , 2,6-(2,4,6-triphenylphenyl) 2 C 6 H 3 , 2,6-(3,5-di-t-butylphenyl) 2 C 6 H 3 , 2,6-(2,6-dichlorphenyl) 2 C 6 H 3 , 2,6-(2,4,6-trichlorophenyl) 2 C 6 H 3 , 2,4,6-(mesityl) 3 C 6 H 2 , 2,3,5,6-(phenyl) 4 C 6 H, or 2,3,4,5,6-(phenyl) 5 C 6 ; R 5 is —Cl or Br; R 6 is selected from the group consisting of an ether, a nitrile, a phosphine, a pyridine, and an amine; and n is 0-2. 2. The method of claim 1 , wherein the method is performed in the presence of a compound selected from the group consisting of: trityl tetrakis(pentafluorophenyl)borate [(C 6 H 5 ) 3 CB(C 6 F 5 ) 4 ], sodium tetrakis[3,5-bis(trifluoromethyl)phenyl]borate [Na(B[3,5-(CF 3 ) 2 C 6 H 3 ] 4 )], tris(pentafluorophenyl)boron [B(C 6 F 5 ) 3 ], dimethylanilinium tetrakis(pentafluorophenyl) borate [PhNMe 2 HB(C 6 F 5 ) 4 ], and CuCI. 3. The method of claim 1 , wherein the compound of formula I-a is selected from: Mo(NAd)(CHCMe 2 Ph)(OHMT)(Br)(py), Mo(NAd)(CHR)(OHMT)(Cl)(py), Mo(NAd)(CHR)(OHMT)(Br)(MeCN), Mo(NAd)(CHR)(OHMT)(Cl)(MeCN), Mo(NC 6 F 5 )(CHR)(OHMT)(Br)(py), Mo(NC 6 F 5 )(CHR)(OHMT)(Cl)(py), Mo(N-t-Bu)(CHCMe 2 Ph)(OHMT)(Cl)(MeCN), Mo(N-t-Bu)(CHCMe 2 Ph)(OHIPT)(Cl)(MeCN), Mo(N-t-Bu)(CHCMe 2 Ph)(OTBT)(Cl)(MeCN), Mo(NAd)(CHR)(OHMT)(Br), Mo(NAd)(CHR)(OHMT)(Cl)(ADNH 2 ), Mo(N-t-Bu)(CHt-Bu)(OHMT)(Cl)(MeCN), Mo(N-t-Bu)(CHt-Bu)(OHMT)(Br)(MeCN), Mo(N-t-Bu)(CHt-Bu)(OHIPT)(Cl)(MeCN), Mo(NC 6 F 5 )(CHR)(OHMT)(Cl)(PhMe 2 P), Mo(NC 6 F 5 )(CHR)(OHIPT)(Cl)(PhMe 2 P), and Mo(NC 6 F 5 )(CHR)(OHMT)(Cl)(Me 3 P), wherein Ad is adamant-1-yl, AdNH 2 is 1-amino-adamantane, py is pyridine, Ph is phenyl, Me is methyl, R is —CMe 2 Ph, OHMT is O-2,6-(mesityl) 2 C 6 H 3 , OHIPT is O-2,6-(2,4,6-(i-Pr) 3 C 6 H 2 ) 2 C 6 H 3 , and OTBT is O-2,6-(3,5-(di-t-Bu-phenyl) 2 C 6 H 3 ).

Assignees

Inventors

Classifications

  • alkene metathesis · CPC title

  • C07C17/275Primary

    of hydrocarbons and halogenated hydrocarbons · CPC title

  • Carbenes or carbynes, i.e.(image) · CPC title

  • Oxygen, e.g. acetylacetonates · CPC title

  • by isomerisation; by change of size of the carbon skeleton (introduction or elimination of carboxyl groups C07C67/313, C07C67/32) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11020730B2 cover?
The present disclosure provides compounds, compositions, and methods for preparing alkenyl halides and/or haloalkyl-substituted olefins with Z-selectivity. The methods are particularly useful for preparing alkenyl fluorides such as CF 3 -substituted olefins by means of cross-metathesis reactions using halogen-containing molybdenum and tungsten complexes.
Who is the assignee on this patent?
Massachusetts Inst Technology, Trustees Boston College
What technology area does this patent fall under?
Primary CPC classification C07C17/275. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jun 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).